Key result
cTnI matches CKMB sensitivity but provides higher specificity and diagnostic efficiency for acute MI.
Why the study?
The diagnostic performance of cardiac troponin I compared to CKMB for acute myocardial infarction and in patients with skeletal muscle damage was evaluated.
Does the cardiac troponin I (cTnI) assay improve diagnostic specificity and efficiency compared to CKMB for diagnosing acute myocardial infarction?
Observational
Does the cardiac troponin I (cTnI) assay improve diagnostic specificity and efficiency compared to CKMB for diagnosing acute myocardial infarction?
Cardiac troponin I demonstrates superior specificity and overall diagnostic efficiency compared to CKMB for diagnosing acute myocardial infarction, particularly in patients with concurrent skeletal muscle damage.
Answers are grounded in this paper and cite their sources.
May support cTnI preference over CKMB for AMI diagnosis; leaves open prospective validation before practice change.
Cardiac troponin I (cTnI) has been reported to be a highly specific marker for cardiac injury. We investigated the performance of this assay in patients admitted to a coronary care unit for suspected acute myocardial infarction (AMI), patients with extensive skeletal muscle damage, marathon runners and as a routine diagnostic test over a four week period. cTnI proved to be as sensitive a marker for AMI as creatine kinase/MB isoenzyme (CKMB) in patients admitted to the coronary care unit. In 10 patients with a proven AMI, the cTnI remained elevated from 69 to 183 h with a median time of 127 h. Cardiac troponin I had superior specificity to CKMB in patients with skeletal muscle damage. It was very useful in these patients to confirm or exclude concurrent myocardial damage. In routine diagnostic use, cTnI had greater efficiency than CKMB to classify patients as having an AMI. Consequently cTnI should replace CKMB as a marker for AMI.
No takes yet. Share an insight, caveat, or question.
Bhagat et al. (1997) conducted an observational in Suspected acute myocardial infarction. Cardiac troponin I (cTnI) assay vs. Creatine kinase/MB isoenzyme (CKMB) assay was evaluated on Diagnosis of acute myocardial infarction (sensitivity, specificity, and efficiency). Cardiac troponin I (cTnI) was as sensitive and more specific than CKMB for diagnosing acute myocardial infarction, with greater diagnostic efficiency in routine use.
Synapse has enriched 10 related papers. Consider them for comparative context: